Kirsti Ss Steen

Learn More
BACKGROUND Maintenance use of nonsteroidal anti-inflammatory drugs (NSAIDs) is often complicated by gastropathy. In non-NSAID users, eradication of Helicobacter pylori is associated with decreased mucosal inflammation, and may halt the progression to atrophy and intestinal metaplasia, but the continuous use of NSAIDs may interfere with these processes. (More)
  • Pharma Falk, B V Benelux, B V Ferring, B V Astrazeneca, B V Abbvie, Dr L M Bouter +64 others
  • 2013
Helicobacter pylori and non-steroidal anti-inflammatory drugs in patients with rheumatic diseases Helicobacter pylori and non-steroidal anti-infl ammatory drugs in patients with rheumatic diseases All rights reserved. No part of this thesis may be reproduced, stored in a database or retrieval system, or published, in any form or in any way, electronically,(More)
The treatment of choice of H. pylori infections is a 7-day triple-therapy with a proton pump inhibitor (PPI) plus amoxicillin and either clarithromycin or metronidazole, depending on local antibiotic resistance rates. The data on efficacy of eradication therapy in a group of rheumatology patients on long-term NSAID therapy are reported here. This study was(More)
  • 1